Log In

Forgot Password?
Create New Account

Loading... please wait

2021 Annual Meeting | Neuromuscular and Clinical Neurophysiology (EMG) Posters

This program spans the entire conference
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
Scientific Poster Session
Neuromuscular and Clinical Neurophysiology (EMG)
0.00 credit
COVID-19

Program Materials Program Evaluations

Event Timeline
07:00 AM - 05:00 PM EDT Abstract 001 - Randomized, Double-blind Controlled Trial Assessing The Dose Response And Safety Of Deflazacort In Boys With Duchenne Muscular Dystrophy
07:00 AM - 05:00 PM EDT Abstract 002 - Clinical and electrophysiological features in a large cohort of myotonic dystrophy patients
Mailin Oliva, MD
07:00 AM - 05:00 PM EDT Abstract 003 - Anti-Adeno-Associated virus (AAV) neutralizing antibody (Nab) titers in Duchenne muscular dystrophy (DMD)
Sumit Verma, MD
07:00 AM - 05:00 PM EDT Abstract 004 - Isoform Specific Variant as a Potential Cause of Distal Myopathy
07:00 AM - 05:00 PM EDT Abstract 005 - Prognostic value of miR-206 in detecting evolution of Limb Girdle D2 due to TPNO3 gene mutation
07:00 AM - 05:00 PM EDT Abstract 006 - 24-week open label clinical trial to test safety and efficacy of oral weekly prednisone in adults with Becker (BMD) and Limb-Girdle Muscular Dystrophy (LGMD).
Aaron Zelikovich, MD
07:00 AM - 05:00 PM EDT Abstract 007 - VCP inhibitor CB-5083: a potential treatment for VCP Inclusion Body Myopathy
Cheng Cheng, PhD
07:00 AM - 05:00 PM EDT Abstract 008 - Results of Double-blind, Placebo-controlled, Dose Range Finding, Crossover Study of Single Day Administration of ERX-963 (IV Flumazenil) in Adults with Myotonic Dystrophy Type 1
Jacinda B. Sampson, MD, PhD
07:00 AM - 05:00 PM EDT Abstract 009 - The Outcomes and Experience of Pregnancy in Limb Girdle Muscular Dystrophy Type R9
Eric Libell, MD
07:00 AM - 05:00 PM EDT Abstract 010 - Myo-MiRNAs ,Myostatin as Biomarkers for Becker Muscular Dystrophy.
07:00 AM - 05:00 PM EDT Abstract 011 - Severe adolescent-onset limb-girdle muscular dystrophy due to a novel homozygous nonsense BVES mutation
Grayson B. Beecher, MD
07:00 AM - 05:00 PM EDT Abstract 012 - Two cases of limb-girdle muscular dystrophy and congenital myasthenic syndrome due to compound heterozygous variants in GMPPB
Stefanie Wolf, MD
07:00 AM - 05:00 PM EDT Abstract 013 - Progressive Muscular Dystrophy in Adults from Mutations in LAMA2 Gene
V V. Vedanarayanan, MD, FRCPC
07:00 AM - 05:00 PM EDT Abstract 014 - Utilizing patient-derived induced pluripotent stem cells to investigate GNE myopathy
Rebecca E. Schmitt, PhD
07:00 AM - 05:00 PM EDT Abstract 015 - Novel RYR1 Missense Mutation as Potential Pathogenic Variant in Malignant Hyperthermia
Jessica Frey, MD
07:00 AM - 05:00 PM EDT Abstract 016 - North African Family With Recessive PYROXD1 Mutation Cause Adult-Onset Limb-Girdle-Type Muscular Dystrophy.
Mohammad I. Alhatou, MD
07:00 AM - 05:00 PM EDT Abstract 017 - Late-onset Multiple acyl-CoA dehydrogenase deficiency with proximal myopathy
07:00 AM - 05:00 PM EDT Abstract 018 - Use of Artificial Intelligence to Identify Risk Factors Predictive of Wheelchair Use in Patients with Fascioscapulohumeral Muscular Dystrophy (FSHD)
Natalie Katz, MD, PhD
07:00 AM - 05:00 PM EDT Abstract 019 - Camptocormia with novel FLNC mutation: A Case Report
Sara Hooshmand, MD
07:00 AM - 05:00 PM EDT Abstract 020 - Recognition and Management of Duchenne Muscular Dystrophy: Knowledge and Behavior Changes from Continuing Education
Carole Drexel
07:00 AM - 05:00 PM EDT Abstract 021 - Duchenne Muscular Dystrophy Phenotype in Two Brothers with a Rare Splice Site Mutation Genotype
Michael Todinca, MD
07:00 AM - 05:00 PM EDT Abstract 022 - A novel mutation in desmin gene causing desmin myopathy
Swathi Beladakere Ramaswamy, MD
07:00 AM - 05:00 PM EDT Abstract 023 - Novel LMNA mutation presenting with cardiomyopathy, paraspinal muscle atrophy and proximal lower extremity weakness.
Brian J. Villafuerte Trisolini, MD
07:00 AM - 05:00 PM EDT Abstract 024 - Late-onset TK2-Deficiency Patients from Turkey
Hacer Durmus, MD
07:00 AM - 05:00 PM EDT Abstract 025 - Facioscapulohumeral Muscular Dystrophy Type 2 due to a Novel Pathogenic Variant (c.180_183delGTGT : p.Cys61ArgfsX47) in the SMCHD1 Gene, Confirmed by Molecular Testing: A Case Report
Mathieu Cuchanski, DO
07:00 AM - 05:00 PM EDT Abstract 026 - Characterization of a Muscle-specific Haploinsufficiency in a Congenital Myopathy Family
Jennifer D. Hauteclocque
07:00 AM - 05:00 PM EDT Abstract 027 - TOWARDS A LARGE-SCALE AUDIO-VISUAL CORPUS FOR RESEARCH ON AMYOTROPHIC LATERAL SCLEROSIS
Aria Anvar
07:00 AM - 05:00 PM EDT Abstract 028 - A Clinical Bulbar Assessment Scale for ALS (C-BAS)
Gary L. Pattee, MD
07:00 AM - 05:00 PM EDT Abstract 029 - Time Trajectories of Critical Events in Amyotrophic Lateral Sclerosis Progression
Brian Crum, MD
07:00 AM - 05:00 PM EDT Abstract 030 - The ALS Genetic Access Program: Paving the Way for Genetic Testing, Counseling and Therapy for ALS
Kelly Rich, MS, CGC
07:00 AM - 05:00 PM EDT Abstract 031 - Progressive neurochemical abnormalities in cognitive and motor subgroups of ALS: a multicenter study
Daniel Ta, MD
07:00 AM - 05:00 PM EDT Abstract 032 - A Progressive Increase in Threshold Variability Impacts Mscanfit Motor Unit Number Estimation in the SOD1G93A Mice and Patients with Amyotrophic Lateral Sclerosis
Christian Krarup, MD, DMSc, FRcP, FAAN
07:00 AM - 05:00 PM EDT Abstract 033 - Sporadic ALS cerebrospinal fluid induces pathological translocation of TDP-43 in motor neurons
Taylor Shue
07:00 AM - 05:00 PM EDT Abstract 034 - Analysis of mesenchymal stromal cell phenotype in the cerebrospinal fluid environment via in vitro transcriptomics and in vivo data from an ALS clinical trial
Deborah Setter, MD, PhD
07:00 AM - 05:00 PM EDT Abstract 035 - SOD1 Mutation: A Single Center Experience
Arman Cakar
07:00 AM - 05:00 PM EDT Abstract 036 - The Comprehensive Analysis Platform To Understand, Remedy, and Eliminate ALS (CAPTURE ALS)
Sanjay Kalra, MD
07:00 AM - 05:00 PM EDT Abstract 037 - Comparison of Patterns in Resting-State Brain Activity and Functional Connectivity between Amyotrophic Lateral Sclerosis and Behavioral Variant Frontotemporal Dementia
Rosanne Govaarts, MSc
07:00 AM - 05:00 PM EDT Abstract 038 - Filtration reduces neurotoxicity of sporadic ALS cerebrospinal fluid in a mouse model
Nadia M. Celestin, BS
07:00 AM - 05:00 PM EDT Abstract 039 - Investigating the Genetic Profile of Amyotrophic Lateral Sclerosis in Patients of Diverse Geoancestry
Maysen Mesaros
07:00 AM - 05:00 PM EDT Abstract 040 - NT5c1A Antibodies in Amyotrophic Lateral Sclerosis
Shadi Milani, DO
07:00 AM - 05:00 PM EDT Abstract 041 - Demographic and Survival Analysis of Midwestern Patients with Amyotrophic Lateral Sclerosis via the ALS Association Mid-America Chapter
Mai Yamakawa, MD
07:00 AM - 05:00 PM EDT Abstract 042 - Trends and outcomes in ALS patients with PEG tubes
Tejas R. Mehta, MD
07:00 AM - 05:00 PM EDT Abstract 043 - Factors Contributing to Diagnostic Delay in Amyotrophic Lateral Sclerosis Among Primary Care Providers
John A. Morren, MD, FAAN
07:00 AM - 05:00 PM EDT Abstract 044 - Correlation of laboratory safety variables with disease course in the REFALS phase 3 study of levosimendan in people with ALS
Kira M. Holmström, PhD
07:00 AM - 05:00 PM EDT Abstract 045 - Spinal Cord Cervical and Thoracic Gray Matter Atrophy – an emerging imaging surrogate for Amyotrophic Lateral Sclerosis
Maria Janina Wendebourg, MD
07:00 AM - 05:00 PM EDT Abstract 046 - The role of arterial blood gas analysis (ABG) in Amyotrophic Lateral Sclerosis respiratory monitoring
Andrea Calvo, MD, PhD, FAAN
07:00 AM - 05:00 PM EDT Abstract 047 - Case Series of Six Amyotrophic Lateral Sclerosis Patients with Sarcoidosis
Nicholas S. Streicher, MD
07:00 AM - 05:00 PM EDT Abstract 048 - Prognosis of Pathologically Confirmed Japanese Amyotrophic Lateral Sclerosis, a Retrospective Institute-based Study
Kiyonobu Komai, MD
07:00 AM - 05:00 PM EDT Abstract 049 - Northeast ALS Consortium National COVID-19 ALS Case Rate Census Survey – 2nd Qtr 2020
Benjamin R. Brooks, MD, FAAN
07:00 AM - 05:00 PM EDT Abstract 050 - A Phase 2 Study to Evaluate the Efficacy and Safety of SRK-015 in Patients with Later-Onset Spinal Muscular Atrophy (TOPAZ): A Study Update
Amy Place
07:00 AM - 05:00 PM EDT Abstract 051 - Collateral sprouting in adults with Spinal Muscular Atrophy varies by functional status
Kristina M. Kelly, PT
07:00 AM - 05:00 PM EDT Abstract 052 - Spinal Muscular Atrophy Mimicking Adult-onset GM2 Gangliosidosis AB variant: A Case Report
Zachary Klopman
07:00 AM - 05:00 PM EDT Abstract 053 - Cure SMA Care Center Network and SMA Clinical Data Registry with Electronic Medical Record Integration
Mary K. Schroth, MD
07:00 AM - 05:00 PM EDT Abstract 054 - Self-reported SMN2 Copy Number and Current Motor Function from the Cure SMA Patient Database
Lisa Belter
07:00 AM - 05:00 PM EDT Abstract 055 - EQ-5D and HUI2 Results from the Cure SMA Annual Community Update Survey
Lisa Belter
07:00 AM - 05:00 PM EDT Abstract 056 - Neurofilament Levels in CSF and Serum in an Adult SMA Cohort treated with Nusinersen
Kelly Rich, MS, CGC
07:00 AM - 05:00 PM EDT Abstract 057 - Gene Replacement Therapy for SMA Unmasking Occult Hepatitis Infection
Grant Turek, MD
07:00 AM - 05:00 PM EDT Abstract 058 - Validation of diagnostic criteria for early-stage primary lateral sclerosis: Disease burden in “Probable PLS”
Eoin Finegan, MBBS
07:00 AM - 05:00 PM EDT Abstract 059 - Clinical, Electrophysiological and Genetic Profile of Hereditary Spastic Paraplegia.
Tanya Panwala, MD
07:00 AM - 05:00 PM EDT Abstract 060 - Lenalidomide in Anti-MAG Neuropathy: Phase 1b Study
Amro Stino, MD
07:00 AM - 05:00 PM EDT Abstract 061 - Clinical presentation and management in cryptogenic immune small fiber neuropathy with TS-HDS, FGFR-3, or Plexin-D1 antibodies
Pravesh Saini, MD
07:00 AM - 05:00 PM EDT Abstract 062 - Immune mediated radiculoneuropathy associated with serum anti-Lgi-1 autoantibodies
Bhavesh Trikamji, MD
07:00 AM - 05:00 PM EDT Abstract 063 - Open-label Study of Patisiran in Patients with hATTR Amyloidosis Post-Orthotopic Liver Transplant
Seth Arum
07:00 AM - 05:00 PM EDT Abstract 064 - Two Cases of POEMS Syndrome with Negative Skeletal X-rays Leading to Delayed Diagnosis and Ineffective Treatment
Sarah Heintzman, NP
07:00 AM - 05:00 PM EDT Abstract 065 - NorthShore Neuropathy Impairment Scale (NSNIS): A Validation of an Electronic Medical Record (EMR) Based Neuropathy Scale
Alexandru C. Barboi, MD
07:00 AM - 05:00 PM EDT Abstract 066 - Plasma 1-deoxy-sphingolipid Levels and (Para)clinical Correlations in 100 Idiopathic Small Fiber Neuropathy Patients
Maike Dohrn, MD
07:00 AM - 05:00 PM EDT Abstract 067 - Retrospective Review of Small Fiber Neuropathy in the Pediatric Population
Neha Gandhi, MD
07:00 AM - 05:00 PM EDT Abstract 068 - Devastating Ischemic Monomelic Neuropathy after Plastic zip Tie Handcuffs, Message for Security Agencies.
Ahmed Wali, FCPS
07:00 AM - 05:00 PM EDT Abstract 069 - Prevalence of neuropathy in patients with minimally symptomatic hyperCKemia
Bhavesh Trikamji, MD
07:00 AM - 05:00 PM EDT Abstract 070 - Isoniazid-associated Peripheral Neuropathy in a “Slow Acetylator”: Need for Pharmacogenomics in Tuberculosis treatment?
Christopher Lamb, MD
07:00 AM - 05:00 PM EDT Abstract 071 - An Atypical Presentation of Bortezomib-Induced Peripheral Neuropathy
Ashley Santilli, MD
07:00 AM - 05:00 PM EDT Abstract 072 - Anti-CGRP Monoclonal Antibodies for Neuropathic Pain in Patients with Migraine Headache
Seung Ah Kang
07:00 AM - 05:00 PM EDT Abstract 073 - Brentuximab-induced sensorimotor polyneuropathy with acquired demyelinating features resembling chronic inflammatory demyelinating polyneuropathy (CIDP)
Adeel Zubair, MD
07:00 AM - 05:00 PM EDT Abstract 074 - Clinical Characteristics of Acquired Chronic Autoimmune Polyneuropathies Associated with Nodal/Paranodal Autoantibodies at UCSD Neuromuscular Center
Jonathan Peters, MD
07:00 AM - 05:00 PM EDT Abstract 075 - Patterns in Axonal and Demyelinating Subtypes of Guillain-Barré Syndrome
Peter Q. Mai, MD
07:00 AM - 05:00 PM EDT Abstract 076 - Nivolumab-induced Immune-mediated Chronic Inflammatory Demyelinating Polyneuropathy: A Case Report
Michael A. Perez, MD
07:00 AM - 05:00 PM EDT Abstract 077 - Cognitive involvement in transthyretin-related familial amyloid polyneuropathy (TTR-FAP)
Hacer Durmus, MD
07:00 AM - 05:00 PM EDT Abstract 078 - Genetic polyneuropathy in a teenage girl with pathogenic variants in TTR and WARS genes
Eleanor V. Thomas, MD, PhD
07:00 AM - 05:00 PM EDT Abstract 079 - Thirty-three Years to Diagnosis: Distal Hereditary Motor Neuropathy Type VA with a Novel Variant in BSCL2
John Herbst, DO
07:00 AM - 05:00 PM EDT Abstract 080 - Novel MME mutation (N689K) in an Argentine case with Charcot-Marie-Tooth and family history of pes cavus
Micaela Kennedy, MSc
07:00 AM - 05:00 PM EDT Abstract 081 - NGS as a diagnostic tool for CMT Disease: The experience at Sarah Network of Rehabilitation Hospitals
Eduardo B. Uchoa Cavalcanti, MD, PhD, MSc, FAAN
07:00 AM - 05:00 PM EDT Abstract 082 - Unusual phenotypical findings in two unrelated Belgian patients with Charcot-Marie-Tooth disease, dominant intermediate E (CMT-DIE)
Gauthier Remiche, MD
07:00 AM - 05:00 PM EDT Abstract 083 - Expanding the phenotypical spectrum of SACS mutation: A Single Center Experience
Arman Cakar
07:00 AM - 05:00 PM EDT Abstract 084 - A Unique Phenotype of a Novel AIFM1 Gene Mutation: Case Report and Literature Review.
Oday Halhouli, MD
07:00 AM - 05:00 PM EDT Abstract 085 - Evaluation of Patisiran With Concomitant or Prior Use of Transthyretin Stabilizers
Madeline Merkel
07:00 AM - 05:00 PM EDT Abstract 086 - Prognostic Factors and Outcomes in Patients with Guillain-Barré Syndrome Requiring Invasive Mechanical Ventilation
Adib Jorge De Sarachaga, MD
07:00 AM - 05:00 PM EDT Abstract 087 - Facial diplegia with paresthesias associated with GD1a antibodies
Jason C. Strawbridge
07:00 AM - 05:00 PM EDT Abstract 088 - Erythromelalgia in a Child with V400M Mutation in SCN9A Gene
Chineze Nwebube, MD
07:00 AM - 05:00 PM EDT Abstract 089 - Intravascular Large B-cell Lymphoma Presenting as Lumbosacral Radiculopathy
Feryal Nauman, MBBS
07:00 AM - 05:00 PM EDT Abstract 090 - Automated Muscle Fat Fraction Quantification through MRI and Deep Learning to Track Axonal Loss in Peripheral Nerve Diseases
Yongsheng Chen, PhD
07:00 AM - 05:00 PM EDT Abstract 091 - Brain Degeneration in ALS vs ALS-FTD is Not on a Continuum as Revealed by MRI White Matter Graph Theory Network Analysis
Erik P. Pioro, MD, DPhil, FAAN
07:00 AM - 05:00 PM EDT Abstract 092 - Observing patterns in MRI with QSM in Patients with SOD1 Genetic ALS
Robin Warner, DO
07:00 AM - 05:00 PM EDT Abstract 093 - Neuromuscular Ultrasound Findings in Carpal Tunnel Syndrome with Symptoms Mainly in the Nondominant Hand
Pitcha Chompoopong, MD
07:00 AM - 05:00 PM EDT Abstract 094 - New Keys to Early Diagnosis: Ultrasound Patterns, Electrodiagnostics, and Clinical Scores in 150 Patients with Hereditary Polyneuropathies
Natalie Winter
07:00 AM - 05:00 PM EDT Abstract 095 - A Longitudinal Motor Unit Number Index (MUNIX) Estimation Study in Poliomyelitis
Taha Omer, MD
07:00 AM - 05:00 PM EDT Abstract 096 - Analysis of the Duke Myasthenia Gravis (MG) Clinic Registry: Thymectomy
Shruti M. Raja, MD
07:00 AM - 05:00 PM EDT Abstract 097 - Assessment of the Prevalence of Physical and Mental Fatigue in Myasthenia Gravis and Its Correlation with Other Motor and Nonmotor Symptoms
Tulin Tanridag
07:00 AM - 05:00 PM EDT Abstract 098 - The Evolution of Myasthenia Gravis-Activities of Daily Living (MG-ADL) Scale Utilization to Measure Myasthenia Gravis Symptoms and Treatment Response
Srikanth Muppidi, MD, FAAN
07:00 AM - 05:00 PM EDT Abstract 099 - Review of Dispensing Data and Patient Reported Outcome Measures (PROMs) in Myasthenia Gravis (MG) and Lambert-Eaton Syndrome (LES) Patients Prescribed Immunoglobulin (Ig) and Eculizumab by a Specialty Infusion Pharmacy Using SoleMetricsTM
07:00 AM - 05:00 PM EDT Abstract 100 - Seronegative Myasthenia Gravis: A Retrospective Review of the Clinical Characteristics at a Large Academic Center
Jonathan Morena, DO
07:00 AM - 05:00 PM EDT Abstract 101 - An unusual case of MuSK- Congenital Myasthenic Syndrome
Alexandra Montalvo Acevedo, MD
07:00 AM - 05:00 PM EDT Abstract 102 - Immune-mediated Rippling Muscles with and without Myasthenia Gravis
Carl F. Ansevin, MD, FAAN
07:00 AM - 05:00 PM EDT Abstract 103 - Rituximab in refractory myasthenia gravis: experience in a single healthcare center in Mexico.
Javier A. Galnares-Olalde, Jr., MD
07:00 AM - 05:00 PM EDT Abstract 104 - Clinical Experience with Eculizumab in Treatment-Refractory Acetylcholine Receptor Antibody-Positive Generalized Myasthenia Gravis
Nakul Katyal, MD
07:00 AM - 05:00 PM EDT Abstract 105 - Congenital Myasthenic Syndrome Due to a Novel Compound Heterozygous AGRN Gene Variant
Andrew J. Zhang, MD
07:00 AM - 05:00 PM EDT Abstract 106 - More prominent fibrosis of the cricopharyngeal muscle caused upper esophageal achalasia in inclusion body myositis
Kenichiro Taira, MD, PhD
07:00 AM - 05:00 PM EDT Abstract 107 - Clinical Correlates of Blood KLRG1+ T cells in Inclusion Body Myositis
Namita Goyal, MD, FAAN
07:00 AM - 05:00 PM EDT Abstract 108 - Examining factors influencing progression of inclusion body myositis: analysis of an international patient-reported registry
Bhaskar Roy, MD, FAAN
07:00 AM - 05:00 PM EDT Abstract 109 - Inclusion Body Myositis: Correlation of Clinical Outcomes with Histopathological, Electromyographic and Laboratory Findings
Marcus Vinicius R. Pinto, MD
07:00 AM - 05:00 PM EDT Abstract 110 - Increased Mortality and Higher Frequency of Hematologic Malignancies in Inclusion Body Myositis: A Population-Based Case-Control Study
Elie Naddaf, MD
07:00 AM - 05:00 PM EDT Abstract 111 - Anti-cN1A Antibodies do not Help Characterize sIBM
Pritikanta Paul, MD
07:00 AM - 05:00 PM EDT Abstract 112 - Modulation of Heat Shock Protein B8 by Colchicine: A Promising Therapy for an Inclusion Body Myopathy
Lan Weiss, PhD
07:00 AM - 05:00 PM EDT Abstract 113 - A 40-year population-based epidemiologic study of sporadic inclusion body myositis (sIBM) in Olmsted County, Minnesota
Shahar Shelly, MD
07:00 AM - 05:00 PM EDT Abstract 114 - Anti-signal recognition particle (Anti-SRP) autoantibody myopathy presenting with profound scapular winging and lumbar lordosis: an uncommon presentation
Shadi Milani, DO
07:00 AM - 05:00 PM EDT Abstract 115 - Variable clinical presentation of HMGCR antibody associated necrotizing myopathy
Varun Sreenivasan, MD
07:00 AM - 05:00 PM EDT Abstract 116 - Incidence and impact of COVID-19 in a cohort of patients with myasthenia gravis from Barcelona.
Eugenia Martinez-Hernandez, MD
07:00 AM - 05:00 PM EDT Abstract 117 - Characteristics and Outcomes of Myasthenia Gravis Patients with COVID-19 – A Case Series
Andre Granger, MD, MBA
07:00 AM - 05:00 PM EDT Abstract 118 - Impact of the COVID-19 pandemic on Myasthenia Gravis patients: A survey of the Myasthenia Gravis Foundation of America Registry
Andres De Leon Benedetti, MD
07:00 AM - 05:00 PM EDT Abstract 119 - Myasthenia Gravis After SARS-CoV-2 Infection: A Cerner Real-World COVID-19 De-identified Dataset Analysis
Rishita Patlolla, MD
07:00 AM - 05:00 PM EDT Abstract 120 - Cranial Nerves Manifestations of SARS-CoV-2 Infection: A Cerner Real-World COVID-19 De-identified Dataset Analysis
Claire Ruane
07:00 AM - 05:00 PM EDT Abstract 121 - Acute Skeletal Muscle Injury after SARS-CoV-2 Infection: A Cerner Real-World COVID-19 De-identified Dataset Analysis
07:00 AM - 05:00 PM EDT Abstract 122 - Atypical Presentation of Guillain-Barré Syndrome (GBS) with Facial Diplegia and Retained Reflexes associated with COVID-19 Infection
Puja Jain, MD
07:00 AM - 05:00 PM EDT Abstract 123 - Guillain Barre Syndrome as a Complication of COVID-19: A Systematic Review
Mohammad A. Aladawi, MD
07:00 AM - 05:00 PM EDT Abstract 124 - Patient Preference in Virtual Versus In-Person Visits in Neuromuscular Clinical Practice, a Multicenter Survey
Fnu Komal, MBBS
07:00 AM - 05:00 PM EDT Abstract 125 - Chloroquine and Hydroxychloroquine Myopathy: Clinical Spectrum and Treatment Outcomes
Elie Naddaf, MD
07:00 AM - 05:00 PM EDT Abstract 126 - Immune checkpoint inhibitor-associated myopathy: Clinicoseropathological Phenotype and Survival Analysis
Shahar Shelly, MD
07:00 AM - 05:00 PM EDT Abstract 127 - Neuromuscular complications of Immune checkpoint inhibitors.
Mohammed W. Rahman, DO
07:00 AM - 05:00 PM EDT Abstract 128 - Necrotizing autoimmune myopathy: unusual presentations of a treatable disease
Stefan Nicolau, MD
07:00 AM - 05:00 PM EDT Abstract 129 - Myopathy after Influenza Vaccination in the United States: A CDC/FDA Vaccine Adverse Event Reporting System Study, 1990-2018
Nour Jedidi
07:00 AM - 05:00 PM EDT Abstract 130 - Neuromyotonia and encephalopathy with neuronal-type voltage-gated calcium channel antibodies and prostate adenocarcinoma
Taha Qarni, MD
07:00 AM - 05:00 PM EDT Abstract 131 - COMPARISON OF DELTA BRUSH EEG PATTERNS IN EPILEPSIES RELATED TO ANTI-NMDAR ENCEPHALITIS AND LUPUS CEREBRITIS
Haroon Majoka, MD
07:00 AM - 05:00 PM EDT Abstract 132 - Structured Review of Opportunistic Infections in Neuromuscular Disease
Sun Qiu, MD
07:00 AM - 05:00 PM EDT Abstract 133 - HyperCKemia in Patients with Legionella Infection
Jeremy Hill, MD
07:00 AM - 05:00 PM EDT Abstract 134 - Mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes (MELAS) syndrome: frequency, clinical features, imaging, histopathologic and molecular genetic findings in a third-level healthcare center in Mexico.
Javier A. Galnares-Olalde, Jr., MD
07:00 AM - 05:00 PM EDT Abstract 135 - Charcot-Marie-Tooth disease: genetic profile of 500 patients from a large Brazilian neuromuscular center
Eduardo B. Uchoa Cavalcanti, MD, PhD, MSc, FAAN
07:00 AM - 05:00 PM EDT Abstract 136 - Diagnostic Outcome Of Genetic Testing on Neuromuscular Disorders in a Tertiary Center
Husam Al Sultani
07:00 AM - 05:00 PM EDT Abstract 137 - Neuromuscular Clinician Preferences and Experience in the Management of Myasthenic Crisis
Jeffrey Mullen, MD
07:00 AM - 05:00 PM EDT Abstract 138 - In 1001 Consecutive Patients Referred to an Academic Neuromuscular Clinic a Range of Neurologic and Non-neurologic Conditions were Diagnosed
Benn E. Smith, MD, FAAN
07:00 AM - 05:00 PM EDT Abstract 139 - Evaluation of quality of life of patients with rare neuromuscular diseases in a University Hospital in Rio de Janeiro / Brazil
Karina L. Pires, MD
07:00 AM - 05:00 PM EDT Abstract 140 - Multimodal Assessment of Intensive Care Unit-Acquired Weakness in Severe Stroke Patients
Berin Inan
07:00 AM - 05:00 PM EDT Abstract 141 - Determinants of the Repetitive-CMAP Occurrence and Therapy Efficacy in Slow-Channel Myasthenia
07:00 AM - 05:00 PM EDT Abstract 142 - Electrophysiological factors related to poor short-term functional prognosis in Guillain-Barré syndrome
Anna L. Bazan, MD
07:00 AM - 05:00 PM EDT Abstract 143 - Persistent Median Artery Thrombosis: A Rare Cause of Carpal Tunnel Syndrome
Ashley Santilli, MD
07:00 AM - 05:00 PM EDT Abstract 144 - Marked Reduction in Paralytic Attacks in Patient With Andersen-Tawil Syndrome Switched From Acetazolamide to Dichlorphenamide: A Case Report
Anirudh Gupta, MD, PhD
07:00 AM - 05:00 PM EDT Abstract 145 - Clinical experience with Dichlorphenamide in Refractory Hyperkalemic Periodic Paralysis with SCN4 Gene Mutation.
Nakul Katyal, MD
07:00 AM - 05:00 PM EDT Abstract 146 - Atypical Periodic Paralysis Presentations
Nivedita Jerath, MD
07:00 AM - 05:00 PM EDT Abstract 147 - Quick and long-lasting responsiveness by ephedrine in an adult woman with congenital myasthenic syndrome associated with a novel COLQ mutation.
Kazuhiro Higashida
Faculty Disclosures
Jafar Kafaie, MD, PhD Dr. Kafaie has nothing to disclose.
No disclosure on file
Neha Gandhi, MD Dr. Gandhi has nothing to disclose.
Amy Place Amy Place has received personal compensation for serving as an employee of Scholar Rock. Amy Place has received personal compensation in the range of $0-$499 for serving as an Expert Witness for Tegus. Amy Place has stock in Scholar Rock.
Benjamin R. Brooks, MD, FAAN Dr. Brooks has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Mitsubishi Tanabe Pharma America. Dr. Brooks has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Medicinova. Dr. Brooks has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Brooks has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AB Science. Dr. Brooks has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ionis. Dr. Brooks has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Mitsubishi Tanabe Pharma America. Dr. Brooks has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Muscular Dystrophy Association. The institution of Dr. Brooks has received research support from Mitsubishi TanabePharma America. Dr. Brooks has received personal compensation in the range of $0-$499 for serving as a Member Annual Surveillance Committee CDC National ALS Registry with Center for Disease Control Agency Toxic Substances Disease Registry. Dr. Brooks has a non-compensated relationship as a Member ALS Quality Measures Subcommittee with American Academy of Neurology that is relevant to AAN interests or activities.
Taha Omer, MD Dr. Omer has nothing to disclose.
Andrew J. Zhang, MD Dr. Zhang has nothing to disclose.
Duygu Selcen, MD, FAAN The institution of Dr. Selcen has received research support from NIH.
David C. Preston, MD, FAAN Dr. Preston has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for FBI, US Attorney, Insurance Fraud Investigative Units. Dr. Preston has received publishing royalties from a publication relating to health care.
Urvi G. Desai, MD, FAAN Dr. Desai has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Desai has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Desai has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda. Dr. Desai has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Desai has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Fulcrum. Dr. Desai has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Catalyst. Dr. Desai has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Desai has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Desai has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Argenx.
Eduardo B. Uchoa Cavalcanti, MD, PhD, MSc, FAAN Dr. Uchoa Cavalcanti has nothing to disclose.
Pritikanta Paul, MD Dr. Paul has nothing to disclose.
Ryan D. Jacobson, MD Dr. Jacobson has nothing to disclose.
Wendy Johnston, MD, FRCP(C) Dr. Johnston has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi Tanabe. Dr. Johnston has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen Inc.. Dr. Johnston has a non-compensated relationship as a Board Member with ALS Canada that is relevant to AAN interests or activities. Dr. Johnston has a non-compensated relationship as a Chair with Canadian ALS Clinical Research Group that is relevant to AAN interests or activities.
Anna L. Bazan, MD Dr. Bazan has nothing to disclose.
Mehmet E. Yalvac, PhD Dr. Yalvac has nothing to disclose.
Mary Clare McKenna, MB BCh BAO PhD Dr. McKenna has nothing to disclose.
Rebecca E. Schmitt, PhD Rebecca Schmitt has nothing to disclose.
Betul Gundogdu, MD Dr. Gundogdu has nothing to disclose.
William P. Flavin, MD, PhD Dr. Flavin has nothing to disclose.
Gary L. Pattee, MD The institution of Dr. Pattee has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MTPA pharmaceuticals. The institution of Dr. Pattee has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MTPA pharmaceiticals. The institution of Dr. Pattee has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Catalyst. The institution of Dr. Pattee has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for General Dynamics US military. The institution of Dr. Pattee has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Otsuka pharmaceuticals.
Mohamed Ghamoodi Mohamed Ghamoodi has nothing to disclose.
Enrique Gomez Figueroa, MD, MSc Dr. Gomez Figueroa has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen Mexico. Dr. Gomez Figueroa has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Astra Zeneca Mexico. Dr. Gomez Figueroa has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Johnson & Johnson LATAM.
Felix E. Diehn, MD Dr. Diehn has nothing to disclose.
Laura Sander, MD Dr. Sander has nothing to disclose.
Thorsten Hornemann No disclosure on file
Tiffany K. Grider, MS, CGC Ms. Grider has received personal compensation in the range of $0-$499 for serving as a author of educational material with Muscle Dystrophy Association.
Can Ebru Kurt, MD Can Ebru Kurt has nothing to disclose.
Martin Genco MARTIN RAGGIO has nothing to disclose.
Pinar Kahraman Koytak, MD Dr. Kahraman Koytak has nothing to disclose.
Jessica Frey, MD The institution of Dr. Frey has received research support from Tourette Association of America.
Taylor Shue Miss Shue has nothing to disclose.
Anirudh Gupta, MD, PhD Dr. Gupta has nothing to disclose.
Yuji Takahashi, MD, PhD The institution of Dr. Takahashi has received research support from Nihon Medi-Physics Co. Limit.. The institution of Dr. Takahashi has received research support from Takeda Pharmaceutical Company Limited.
Carol Rheaume Ms. Rheaume has nothing to disclose.
Taha Qarni, MD Dr. Qarni has nothing to disclose.
Deaa Abu-Jazar, MD Dr. Abu-Jazar has nothing to disclose.
William D. Arnold, MD Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for La Hoffmann Roche. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cadent Therapeutics . Dr. Arnold has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Arnold has received research support from NIH. The institution of Dr. Arnold has received research support from NMD Pharma. The institution of Dr. Arnold has received research support from Gilead Sciences. The institution of Dr. Arnold has received research support from CureSMA. Dr. Arnold has received intellectual property interests from a discovery or technology relating to health care.
Megan G. Pino Ms. Pino has nothing to disclose.
Connie G. Tang, MD Dr. Tang has nothing to disclose.
Christian Krarup, MD, DMSc, FRcP, FAAN Dr. Krarup has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Shire/Takeda. Dr. Krarup has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Shire/Takeda. Dr. Krarup has received publishing royalties from a publication relating to health care.
Sachin M. Bhagavan, MD Dr. Bhagavan has nothing to disclose.
Miriam L. Freimer, MD, FAAN Dr. Freimer has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for argenx. Dr. Freimer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for alexion. Dr. Freimer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for J and J. The institution of Dr. Freimer has received research support from Alnylum. The institution of Dr. Freimer has received research support from UCB. The institution of Dr. Freimer has received research support from NIH. The institution of Dr. Freimer has received research support from Janssen. Dr. Freimer has received research support from Avidity. Dr. Freimer has received research support from Fulcrum. Dr. Freimer has received personal compensation in the range of $10,000-$49,999 for serving as a presenations/teaching with UCB.
Suur Biliciler, MD Dr. Biliciler has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Efficient CME. Dr. Biliciler has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Argenyx.
Nathan P. Staff, MD, PhD, FAAN Dr. Staff has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Stem Cell Research & Therapy. Dr. Staff has received research support from National Institutes of Health.
Jeremy Hill, MD Dr. Hill has nothing to disclose.
Demetrius M. Maraganore, MD, FAAN The institution of Dr. Maraganore has received research support from Agency for Healthcare Research and Quality. The institution of Dr. Maraganore has received research support from Florida Department of Health.
Steven A. Greenberg, MD Dr. Greenberg has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abcuro, Inc.. The institution of Dr. Greenberg has received research support from NIH. Dr. Greenberg has received intellectual property interests from a discovery or technology relating to health care.
Eric Lancaster, MD, PhD Dr. Lancaster has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for merck. Dr. Lancaster has received intellectual property interests from a discovery or technology relating to health care. Dr. Lancaster has received personal compensation in the range of $50,000-$99,999 for serving as a Expert and Witness with US Vaccine Injury Compensation Program.
Gabriel R. Arismendi, MD Dr. Arismendi has nothing to disclose.
Sean S. Zadeh, MD Dr. Zadeh has nothing to disclose.
Thomas Brannagan III, MD, FAAN Dr. Brannagan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer. Dr. Brannagan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alnylam. Dr. Brannagan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Grifols. Dr. Brannagan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for CSL. Dr. Brannagan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alnylam. The institution of Dr. Brannagan has received research support from Alnylam. The institution of Dr. Brannagan has received research support from Acceleron. The institution of Dr. Brannagan has received research support from Ionis. The institution of Dr. Brannagan has received research support from Pharnext.
Margherita Milone, MD, FAAN Dr. Milone has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Milone has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology Genetics, AAN. The institution of Dr. Milone has received research support from Mayo Clinic, CCaTS-CBD. The institution of Dr. Milone has received research support from Mayo Clinic, SGP Award. The institution of Dr. Milone has received research support from MDA for Care Center grant. The institution of Dr. Milone has received research support from Regenerative medicine Minnesota.
Simona Treidler, MD Dr. Treidler has nothing to disclose.
Sebastien Audet Mr. Audet has nothing to disclose.
John A. Kamholz, MD Dr. Kamholz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepoint. The institution of Dr. Kamholz has received research support from HDSA.
Madeline Merkel Madeline Merkel has received personal compensation for serving as an employee of Alnylam Pharmaceuticals.
Nathaniel M. Robbins, MD Dr. Robbins has received personal compensation in the range of $0-$499 for serving as a Consultant for Red Nucleus. Dr. Robbins has received personal compensation in the range of $0-$499 for serving as a Consultant for TDG Health. Dr. Robbins has received personal compensation in the range of $0-$499 for serving as a Consultant for Jupiter Life Science Consulting. Dr. Robbins has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Vickery & Shepherd. Dr. Robbins has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for Vaccine Injury Compensation Program. The institution of Dr. Robbins has received research support from Diamond Endowment Fund. The institution of Dr. Robbins has received research support from Reeves Endowment Fund. The institution of Dr. Robbins has received research support from Institute for Ethnomedicine. The institution of Dr. Robbins has received research support from Vertex Pharmaceuticals . Dr. Robbins has received personal compensation in the range of $50,000-$99,999 for serving as a Neurohospitalist with Hayes Locums.
Grayson B. Beecher, MD Dr. Beecher has nothing to disclose.
Wan Yee Kong, MBBS Dr. Kong has nothing to disclose.
Jonathan D. Glass, MD Dr. Glass has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Glass has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Apic Bio. Dr. Glass has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CIRM. Dr. Glass has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Bryan Cave Leighton Paisner. The institution of Dr. Glass has received research support from NIH. The institution of Dr. Glass has received research support from ALS Assoiciation. The institution of Dr. Glass has received research support from Muscular Dystrophy Assoication.
Orla Hardiman, MD, FRCP, FAAN Dr. Hardiman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Wave Pharmaceuticals. Dr. Hardiman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cytokinetics . Dr. Hardiman has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Hardiman has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Taylor and Francis. The institution of Dr. Hardiman has received research support from Science Foundation Ireland. The institution of Dr. Hardiman has received research support from HRB.
Srikanth Muppidi, MD, FAAN Dr. Muppidi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. Dr. Muppidi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for argenx. Dr. Muppidi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB/Ra Pharma. Dr. Muppidi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizont Pharma. Dr. Muppidi has received publishing royalties from a publication relating to health care.
Wali Qayoumi, MD Dr. Qayoumi has nothing to disclose.
Mathieu Cuchanski, DO Dr. Cuchanski has nothing to disclose.
Keyvan Heshmati, MD Dr. Heshmati has nothing to disclose.
Rangariroyashe Chipika Miss Chipika has nothing to disclose.
Puja Jain, MD Dr. Jain has nothing to disclose.
Shruti M. Raja, MD Dr. Raja has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Signant Health. Dr. Raja has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Regeneron. The institution of Dr. Raja has received research support from American Brain Foundation/Myasthenia Gravis Foundation of America Clinician Scientist Development Award.
Fnu Komal, MBBS Dr. Komal has nothing to disclose.
Zeynep Ergül Ülger No disclosure on file
Mazen M. Dimachkie, MD, FAAN Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EcoR1 Capital, LLC. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cello Health BioConsulting, previously Defined Health. Dr. Dimachkie has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Dimachkie has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for CSL Behring. Dr. Dimachkie has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Octapharma. Dr. Dimachkie has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for ArgenX. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Spark Therapeutics. Dr. Dimachkie has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for RAF-5. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Houston NeuroCare. Dr. Dimachkie has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Shire. Dr. Dimachkie has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Catalyst. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kezar. Dr. Dimachkie has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for RaPharma/UCB. Dr. Dimachkie has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for ArgenX. Dr. Dimachkie has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. An immediate family member of Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kezar. Dr. Dimachkie has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Catalyst. Dr. Dimachkie has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Takeda. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for SCHOLAR Rock. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jenssen. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amazentis / Vandria. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Spark Therapeutics. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roivant. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for SANEM. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medlink. Dr. Dimachkie has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for CSL Behring. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Third Rock. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Orphazyme . Dr. Dimachkie has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Astellas. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roivant . Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dianthus. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TACT / Treat NMD. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cabaletta Bio. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clinical Neurological Society of America, Inc . Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ig Society, Inc. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abcuro. Dr. Dimachkie has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Covance / Labcorp. The institution of Dr. Dimachkie has received research support from CSL Behring. The institution of Dr. Dimachkie has received research support from Orphazyme. The institution of Dr. Dimachkie has received research support from FDA-OOPD. The institution of Dr. Dimachkie has received research support from NIH. Dr. Dimachkie has received intellectual property interests from a discovery or technology relating to health care. Dr. Dimachkie has received publishing royalties from a publication relating to health care.
Naveen Sankhyan, MD, MBBS, DM The institution of Dr. Sankhyan has received research support from PTC Therapeutics for a Multicentric RCT. Dr. Sankhyan has received research support from Institute Grant, PGIMER, (Goverment Entity).
Arpita Lakhotia, MD Dr. Lakhotia has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier.
Jonathan Peters, MD Dr. Peters has nothing to disclose.
Bernard Brais, MD Dr. Brais has nothing to disclose.
Carlos A. Luciano, MD, FAAN Dr. Luciano has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Akcea Pharmaceuticals. Dr. Luciano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi-Genzyme. Dr. Luciano has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for SIMED. Dr. Luciano has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Universal Insurance Co.. Dr. Luciano has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Pueblo Supermarket. The institution of Dr. Luciano has received research support from National Institutes of Health. The institution of Dr. Luciano has received research support from Catalyst Pharmaceuticals. Dr. Luciano has received personal compensation in the range of $100,000-$499,999 for serving as a Professor and Chair with University of Puerto Rico.
Ali A. Habib, MD Dr. Habib has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alexion. Dr. Habib has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for argenx. Dr. Habib has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Immunovant. Dr. Habib has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB. Dr. Habib has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Habib has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech/Roche. Dr. Habib has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NMD Pharma. Dr. Habib has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alpine Immune Sciences. Dr. Habib has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Arcellx. Dr. Habib has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon/ Amgen. Dr. Habib has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Grifols. Dr. Habib has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NIH/NINDS. Dr. Habib has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunis Biomedical. Dr. Habib has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hoffman-La Roche. Dr. Habib has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Habib has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for argenx. Dr. Habib has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for UCB. The institution of Dr. Habib has received research support from Alexion. The institution of Dr. Habib has received research support from Horizon/Amgen. The institution of Dr. Habib has received research support from Immunovant. The institution of Dr. Habib has received research support from UCB. The institution of Dr. Habib has received research support from argenx. The institution of Dr. Habib has received research support from CabalettaBio. The institution of Dr. Habib has received research support from Genentech. The institution of Dr. Habib has received research support from Regeneron.
Christine Miller No disclosure on file
Laurie Gutmann, MD, FAAN Dr. Gutmann has received personal compensation in the range of $0-$499 for serving as a Consultant for Entrada Therapeutics. Dr. Gutmann has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Dyne Therapeutics. The institution of Dr. Gutmann has received research support from NIH. The institution of Dr. Gutmann has received research support from Harmony . Dr. Gutmann has received publishing royalties from a publication relating to health care.
Eva M. Kesenheimer, MD Dr. Kesenheimer has nothing to disclose.
Corrado Angelini, MD, FAAN Dr. Angelini has nothing to disclose.
Shahar Shelly, MD Dr. Shelly has nothing to disclose.
Violaine Plante-Bordeneuve, MD Dr. Plante-Bordeneuve has nothing to disclose.
Mohammad A. Aladawi, MD Dr. Aladawi has nothing to disclose.
Michael A. Perez, MD Dr. Perez has nothing to disclose.
John A. Morren, MD, FAAN Dr. Morren has received publishing royalties from a publication relating to health care.
Mai Yamakawa, MD Dr. Yamakawa has nothing to disclose.
Charles Kassardjian, MD Dr. Kassardjian has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Genzyme. Dr. Kassardjian has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Kassardjian has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Kassardjian has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Kassardjian has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Argenx.
Trevor Leighton Trevor Leighton has received personal compensation for serving as an employee of argenx BV. Trevor Leighton has received stock or an ownership interest from argenx BV.
Saud A. Sadiq, MD, MB, FAAN Dr. Sadiq has nothing to disclose.
Shadi Milani, DO Dr. Milani has nothing to disclose.
Rosanne Govaarts, MSc Ms. Govaarts has nothing to disclose.
J. Americo M. Fernandes, Jr., MD, FAAN Dr. Fernandes has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Columbia University. The institution of Dr. Fernandes has received research support from MGH philanthropy (Clene, Seelos, UCB, Biohaven, Prilenia, Denali Therapeutics, Calico Life Sciences. The institution of Dr. Fernandes has received research support from Columbia University. The institution of Dr. Fernandes has received research support from PTC Therapeutics. The institution of Dr. Fernandes has received research support from Clene.
Holly Leonhard, NP Mrs. Leonhard has nothing to disclose.
Raghav Govindarajan, MD, FAAN Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MT pharma. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Catalyst. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche . Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amicus. Dr. Govindarajan has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for MT pharma . Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Catalyst. The institution of Dr. Govindarajan has received research support from Band of Hope . The institution of Dr. Govindarajan has received research support from Alexion. Dr. Govindarajan has received publishing royalties from a publication relating to health care.
Osvaldo J. Nascimento, MD, PhD, FAAN Dr. Nascimento has nothing to disclose.
E. M. Hoffman, DO, PhD Dr. Hoffman has nothing to disclose.
Elie Naddaf, MD The institution of Dr. Naddaf has received research support from NIAMS. The institution of Dr. Naddaf has received research support from American Neuromuscular Foundation. The institution of Dr. Naddaf has received research support from Fulcrum therapeutics. The institution of Dr. Naddaf has received research support from Abcuro.
Tulin Tanridag Tulin Tanridag has nothing to disclose.
Rishita Patlolla, MD Ms. Patlolla has nothing to disclose.
Albert Saiz Albert Saiz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Albert Saiz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Albert Saiz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Albert Saiz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janseen. Albert Saiz has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Albert Saiz has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for novartis. Albert Saiz has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen.
Cheng Cheng, PhD The institution of Cheng Cheng has received research support from CureVCP disease.
Adriano Chio, MD, FAAN Dr. Chio has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cytokinetics. Dr. Chio has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi. Dr. Chio has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen.
Richard J. Nowak, MD Dr. Nowak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion . Dr. Nowak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for argenx. Dr. Nowak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Momenta . Dr. Nowak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunovant . Dr. Nowak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cabaletta Bio . Dr. Nowak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Viela Bio. Dr. Nowak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cour Pharma. The institution of Dr. Nowak has received research support from Ra Pharma. The institution of Dr. Nowak has received research support from Alexion . The institution of Dr. Nowak has received research support from Momenta . The institution of Dr. Nowak has received research support from Immunovant . Dr. Nowak has received research support from argenx. Dr. Nowak has received research support from Viela Bio . Dr. Nowak has a non-compensated relationship as a Member of the Board of Directors with Myasthenia Gravis Foundation of America (MGFA) that is relevant to AAN interests or activities.
Parisorn Thepmankorn Ms. Thepmankorn has received personal compensation for serving as an employee of Johnson and Johnson.
Benn E. Smith, MD, FAAN Dr. Smith has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Smith has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CSP Behring.
V V. Vedanarayanan, MD, FRCPC Dr. Vedanarayanan has nothing to disclose.
Kayihan Uluc, MD Dr. Uluc has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer.
Merit E. Cudkowicz, MD, MSC, FAAN Dr. Cudkowicz has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for biogen. Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for cytokinetics. Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for immunitypharm. Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for denali. The institution of Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for wave. Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for transposon. Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Quralis. Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Regeneron. Dr. Cudkowicz has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neurosense. Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for vectorY. Dr. Cudkowicz has received personal compensation in the range of $0-$499 for serving as a Consultant for Arrowhead. Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Servier. Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eledon. Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for inflectis. Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for roche. Dr. Cudkowicz has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for novartis. Dr. Cudkowicz has received personal compensation in the range of $0-$499 for serving as a Consultant for ono. Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for otsuka. Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for coya. Dr. Cudkowicz has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Locust Walk. Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pasithea. Dr. Cudkowicz has received personal compensation in the range of $50,000-$99,999 for serving as an officer or member of the Board of Directors for Praxis Precision Medicine. Dr. Cudkowicz has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Annals of Neurology . An immediate family member of Dr. Cudkowicz has stock in Sqz. The institution of Dr. Cudkowicz has received research support from NINDS. The institution of Dr. Cudkowicz has received research support from ALSA . The institution of Dr. Cudkowicz has received research support from ALSFAC. The institution of Dr. Cudkowicz has received research support from UCB ra. The institution of Dr. Cudkowicz has received research support from Biohaven. The institution of Dr. Cudkowicz has received research support from Clene nanomedicine. The institution of Dr. Cudkowicz has received research support from prilenia. The institution of Dr. Cudkowicz has received research support from ALS one. The institution of Dr. Cudkowicz has received research support from Seelos. The institution of Dr. Cudkowicz has received research support from Calico. The institution of Dr. Cudkowicz has received research support from denali. The institution of Dr. Cudkowicz has received research support from ITB. Dr. Cudkowicz has received publishing royalties from a publication relating to health care.
Senda Ajroud-Driss, MD, FAAN Dr. Ajroud-Driss has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amylyx Pharmaceuticals. Dr. Ajroud-Driss has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. The institution of Dr. Ajroud-Driss has received research support from ALSA. Dr. Ajroud-Driss has received publishing royalties from a publication relating to health care.
Zaeem A. Siddiqi, MD, PhD Dr. Siddiqi has nothing to disclose.
Daniel Ta, MD Daniel Ta has nothing to disclose.
Pitcha Chompoopong, MD Dr. Chompoopong has nothing to disclose.
Oday Halhouli, MD Dr. Halhouli has nothing to disclose.
Yolanda Blanco Morgado, MD Dr. Blanco Morgado has nothing to disclose.
Alexandru C. Barboi, MD Dr. Barboi has nothing to disclose.
Glenn Lopate, MD Dr. Lopate has nothing to disclose.
Lisa Belter Lisa Belter has received personal compensation for serving as an employee of Cure SMA.
Aashit K. Shah, MD, FAAN The institution of Dr. Shah has received research support from Eisai pharma .
Rachel Logan Rachel Logan has nothing to disclose.
Sabrina Bulancea Sabrina Bulancea has nothing to disclose.
J. David Avila, MD Dr. Avila has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion Pharmaceuticals. Dr. Avila has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alnylam Pharmaceuticals. Dr. Avila has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for argenx. Dr. Avila has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Alexion Pharmaceuticals. Dr. Avila has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB. Dr. Avila has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for AstraZeneca. Dr. Avila has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Takeda.
Alan Pestronk, MD, FAAN The institution of Dr. Pestronk has received research support from RA. The institution of Dr. Pestronk has received research support from Fulcrum. The institution of Dr. Pestronk has received research support from Acceleron. The institution of Dr. Pestronk has received research support from Biogen. The institution of Dr. Pestronk has received research support from Jain. The institution of Dr. Pestronk has received research support from Sanofi. The institution of Dr. Pestronk has received research support from Muscular Dystrophy Association. Dr. Pestronk has received intellectual property interests from a discovery or technology relating to health care.
Markus Weber, MD Dr. Weber has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen Idec. Dr. Weber has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Mitsubishi Tanabe.
Colette G. Donaghy, MC MRCP Colette G. Donaghy, MC MRCP has nothing to disclose.
Nicholas J. Maragakis, MD, FAAN Dr. Maragakis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UptoDate. Dr. Maragakis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Apellis Pharmaceuticals. Dr. Maragakis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amylyx. An immediate family member of Dr. Maragakis has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for National Basketball Association. Dr. Maragakis has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Akava. An immediate family member of Dr. Maragakis has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Johns Hopkins Howard County Medical Center. Dr. Maragakis has stock in Akava. The institution of Dr. Maragakis has received research support from NIH/NINDS. The institution of Dr. Maragakis has received research support from Department of Defense. The institution of Dr. Maragakis has received research support from Maryland Stem Cell Research Fund. Dr. Maragakis has received intellectual property interests from a discovery or technology relating to health care.
Anastasia Zekeridou, MD, PhD, FAAN The institution of Dr. Zekeridou has received research support from Roche/Genentech. Dr. Zekeridou has received intellectual property interests from a discovery or technology relating to health care. Dr. Zekeridou has received intellectual property interests from a discovery or technology relating to health care. Dr. Zekeridou has received intellectual property interests from a discovery or technology relating to health care.
Jacinda B. Sampson, MD, PhD Dr. Sampson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Dyne Therapeutics. Dr. Sampson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Viking Therapeutics. Dr. Sampson has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Sampson has received research support from Marigold Foundation. Dr. Sampson has a non-compensated relationship as a Scientific Advisory Committee with Myotonic Dystrophy Foundation that is relevant to AAN interests or activities.
Michael Todinca, MD Dr. Todinca has nothing to disclose.
Tejas R. Mehta, MD Dr. Mehta has nothing to disclose.
Allan Dietz No disclosure on file
Abu Nasar No disclosure on file
Kiyonobu Komai, MD Dr. Komai has nothing to disclose.
Nasser Mohammed, MBBS Dr. Mohammed has nothing to disclose.
Bob Bucelli, MD, PhD Dr. Bucelli has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen . Dr. Bucelli has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Bucelli has stock in Neuroquestions.com. An immediate family member of Dr. Bucelli has stock in Neuroquestions.com. The institution of Dr. Bucelli has received research support from Biogen. The institution of Dr. Bucelli has received research support from Ionis.
Peter Bede, MD, PhD Dr. Bede has nothing to disclose.
Patrick M. Kwon, MD Dr. Kwon has nothing to disclose.
Lawrence Korngut, MD Dr. Korngut has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Korngut has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi Tanabe. Dr. Korngut has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche.
Jennifer A. Roggenbuck, MS, CGC The institution of Ms. Roggenbuck has received research support from Packard Foundation.
Eleanor V. Thomas, MD, PhD Dr. Thomas has nothing to disclose.
Ethem Murat Arsava, MD Dr. Arsava has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Nutricia. Dr. Arsava has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbott. Dr. Arsava has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Fresenius. Dr. Arsava has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Daichi-Sankyo. Dr. Arsava has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer. Dr. Arsava has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bayer. Dr. Arsava has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Nutricia. Dr. Arsava has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbott. Dr. Arsava has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Arsava has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Pfizer. Dr. Arsava has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Daichi Sankyo. Dr. Arsava has received research support from TUBITAK.
Aria Anvar Aria Anvar has nothing to disclose.
Michael J. Schneck, MD, FAAN An immediate family member of Dr. Schneck has received personal compensation for serving as an employee of Cellcarta. Dr. Schneck has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for HLT Medical. Dr. Schneck has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Miscellaneous legal firms. Dr. Schneck has stock in Baxter Labs. The institution of Dr. Schneck has received research support from NIH.
Saila Upadhyayula, MD Dr. Upadhyayula has nothing to disclose.
Gabriele Mora, MD Dr. Mora has nothing to disclose.
Michael G. Benatar, MBChB, DPhil, FAAN Dr. Benatar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. The institution of Dr. Benatar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Arrowhead. Dr. Benatar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alexion. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Annexon. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UniQure. Dr. Benatar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Immunovant. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cartesian. Dr. Benatar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Horizon. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alector. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Benatar has received intellectual property interests from a discovery or technology relating to health care.
Kazuhiro Higashida Kazuhiro Higashida has nothing to disclose.
Michelle M. Mielke, PhD Dr. Mielke has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Mielke has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Mielke has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Mielke has received personal compensation in the range of $500-$4,999 for serving as a Consultant for LabCorp. Dr. Mielke has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Mielke has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Siemens Healthineers. Dr. Mielke has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sunbird Bio. Dr. Mielke has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai. Dr. Mielke has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Roche. Dr. Mielke has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novo Nordisk.
Rocio C. Garcia Santibanez, MD, FAAN Dr. Garcia Santibanez has nothing to disclose.
Andre Granger, MD, MBA Dr. Granger has nothing to disclose.
Dale J. Lange, MD, FAAN No disclosure on file
Jayawant N. Mandrekar, PhD Dr. Mandrekar has nothing to disclose.
David D. Adams David D. Adams has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for ALNYLAM. David D. Adams has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer.
Bhaskar Roy, MD, FAAN Dr. Roy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion Pharmaceuticals. Dr. Roy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda Pharmaceuticals. Dr. Roy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for argenx. Dr. Roy has stock in Cabaletta bio. . The institution of Dr. Roy has received research support from Martin Shubik Fund for IBM at Yale University. The institution of Dr. Roy has received research support from Abcuro Pharmaceuticals.
Cheryl Smith, MD Dr. Smith has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Catalyst. Dr. Smith has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Smith has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. The institution of Dr. Smith has received research support from Sanofi. The institution of Dr. Smith has received research support from Alexion. The institution of Dr. Smith has received research support from Susan Dorsch Research Fund.
Stefanie Wolf, MD Dr. Wolf has nothing to disclose.
Joost Raaphorst, MD Dr. Raaphorst has nothing to disclose.
Stephen J. Kolb, MD, PhD Dr. Kolb has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AveXis. Dr. Kolb has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for CureSMA. The institution of Dr. Kolb has received research support from NIH. The institution of Dr. Kolb has received research support from AveXis. The institution of Dr. Kolb has received research support from NIH.
Jennifer M. Martinez-Thompson, MD Dr. Martinez-Thompson has nothing to disclose.
Rosangel E. Cruz, MA Ms. Cruz has nothing to disclose.
Michelle L. Mauermann, MD, FAAN The institution of Dr. Mauermann has received research support from IONIS. The institution of Dr. Mauermann has received research support from Alnylam. Dr. Mauermann has received publishing royalties from a publication relating to health care.
Ashley Santilli, MD Dr. Santilli has nothing to disclose.
Xin Ming Shen, PhD, FAAN The institution of Dr. Shen has received research support from NIH. The institution of Dr. Shen has received research support from Myasthenia Gravis Foundation of American.
Leo H. Wang, MD, PhD, FAAN Dr. Wang has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AskBio. Dr. Wang has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Fulcrum Therapeutics. Dr. Wang has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Wang has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi Tanabe. Dr. Wang has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Argenx. Dr. Wang has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avidity. Dr. Wang has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Scholar Rock. The institution of Dr. Wang has received research support from National Institute of Health. Dr. Wang has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant with US Government.
Aileen Cangiano-Heath, MD Dr. Cangiano-Heath has nothing to disclose.
Edward Yu, MD, FAAN Dr. Yu has nothing to disclose.
Benjamin Jiang, MD Dr. Jiang has nothing to disclose.
Maria Eugenia Briseño Godinez No disclosure on file
Samuel Mackenzie, MD, PhD Dr. Mackenzie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Phlow, Corp. Dr. Mackenzie has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Everyday Health, Inc. Dr. Mackenzie has received intellectual property interests from a discovery or technology relating to health care.
Berin Inan Berin Inan has nothing to disclose.
Benison Keung, MD Dr. Keung has nothing to disclose.
Edwin S. Vargas, MD Dr. Vargas has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Sanofi. Dr. Vargas has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for CSL Berhing.
Zachary Klopman Mr. Klopman has nothing to disclose.
Maysen Mesaros Maysen Mesaros has nothing to disclose.
Angela L. Genge, MD Dr. Genge has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AL-S Pharma. Dr. Genge has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Genge has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cytokinetics. Dr. Genge has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amylyx. Dr. Genge has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Quralis. Dr. Genge has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Genge has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MTPA. Dr. Genge has received personal compensation in the range of $0-$499 for serving as a Consultant for WAVE.
Andrew G. Engel, MD, FAAN The institution of Dr. Engel has received research support from NIH.
Ahmed Wali, FCPS Dr. Wali has nothing to disclose.
Nathan McGraw, MD Dr. McGraw has nothing to disclose.
Natalie Winter Natalie Winter has nothing to disclose.
Chineze Nwebube, MD Ms. Nwebube has nothing to disclose.
Lan Weiss, PhD Lan Weiss has nothing to disclose.
Siobhan Hutchinson, MD Dr. Hutchinson has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Hutchinson has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva. Dr. Hutchinson has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Teva.
Daniel Moiseev Daniel Moiseev has nothing to disclose.
Christopher Lamb, MD Dr. Lamb has received research support from Immunovant, Inc.
Mohammad I. Alhatou, MD Dr. Alhatou has nothing to disclose.
Perry Shieh, MD, PhD, FAAN Dr. Shieh has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sarepta. Dr. Shieh has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Shieh has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Shieh has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. Dr. Shieh has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Argenx. Dr. Shieh has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Shieh has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for CSL Behring. Dr. Shieh has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Grifols. Dr. Shieh has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Alexion. Dr. Shieh has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Biogen. Dr. Shieh has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genentech. Dr. Shieh has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Argenx. Dr. Shieh has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Catalyst.
Nakul Katyal, MD Dr. Katyal has nothing to disclose.
Immaculada Aban No disclosure on file
Eoin Finegan, MBBS Dr. Finegan has nothing to disclose.
Kathi Schweikert No disclosure on file
Miguel Chuquilin Arista, MD, FAAN Dr. Chuquilin Arista has received personal compensation in the range of $500-$4,999 for serving as a Item writer with American Academy of Neurology. Dr. Chuquilin Arista has received personal compensation in the range of $500-$4,999 for serving as a Item Writer with American Academy of Neurology. Dr. Chuquilin Arista has received personal compensation in the range of $500-$4,999 for serving as a Item Writer with American Academy of Neurology. Dr. Chuquilin Arista has received personal compensation in the range of $500-$4,999 for serving as a Item reviewer with National Board of Medical Examiners. Dr. Chuquilin Arista has received personal compensation in the range of $500-$4,999 for serving as a Southeast regional advisory board with Argenx. Dr. Chuquilin Arista has received personal compensation in the range of $500-$4,999 for serving as a Focus group with Alexion. Dr. Chuquilin Arista has received personal compensation in the range of $0-$499 for serving as a Speaker with Periodic Paralysis Association.
Hongyan Li, MD, PhD, FAAN Dr. Li has nothing to disclose.
Mohamed Elfil, MBBCh Dr. Elfil has nothing to disclose.
Gauthier Remiche, MD Dr. Remiche has nothing to disclose.
Hani Kushlaf, MD, FAAN Dr. Kushlaf has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion AstraZeneca Rare Disease. Dr. Kushlaf has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Genzyme. Dr. Kushlaf has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunovant. Dr. Kushlaf has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Kushlaf has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sanofi Genzyme.
Marcus Vinicius R. Pinto, MD Dr. Pinto has nothing to disclose.
Cristina Moglia Cristina Moglia has nothing to disclose.
Irfan S. Sheikh, MD Dr. Sheikh has nothing to disclose.
Katherine D. Mathews, MD, FAAN Dr. Mathews has received personal compensation for serving as an employee of Avidity Bioscience. The institution of Dr. Mathews has received research support from NIH. The institution of Dr. Mathews has received research support from Centers for Disease Control and Prevention. The institution of Dr. Mathews has received research support from Muscular Dystrophy Association . The institution of Dr. Mathews has received research support from Friedreich's Ataxia Research Alliance . The institution of Dr. Mathews has received research support from Sarepta . The institution of Dr. Mathews has received research support from Pfizer. The institution of Dr. Mathews has received research support from Reata . The institution of Dr. Mathews has received research support from PTC Therapeutics, Inc. The institution of Dr. Mathews has received research support from Italfarmaco . The institution of Dr. Mathews has received research support from AMO. The institution of Dr. Mathews has received research support from FibroGen. The institution of Dr. Mathews has received research support from Capricor. The institution of Dr. Mathews has received research support from edgewise. The institution of Dr. Mathews has received research support from biogen.
Eric Libell, MD Mr. Libell has nothing to disclose.
Samantha J. LoRusso, MD Dr. LoRusso has nothing to disclose.
Sara Llufriu Sara Llufriu has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Sara Llufriu has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Sara Llufriu has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merci. Sara Llufriu has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbot. Sara Llufriu has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi.
Jeff Guptill, MD, FAAN Dr. Guptill has received personal compensation for serving as an employee of argenx. Dr. Guptill has stock in argenx.
Brenda Deliz Roldan No disclosure on file
Muhammad Hussain, MD Dr. Hussain has nothing to disclose.
Tyler Irani, MD Mr. Irani has nothing to disclose.
Omar Jawdat, MD Dr. Jawdat has nothing to disclose.
Joss Cohen, MD Dr. Cohen has nothing to disclose.
Feryal Nauman, MBBS Dr. Nauman has nothing to disclose.
Lorne H. Zinman, MD Dr. Zinman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen, MTP, AB Science, Cytokinetics, Amylyx. Dr. Zinman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amylyx.
Inna Keselman, MD, PhD Dr. Keselman has nothing to disclose.
Tahseen Mozaffar, MD, FAAN Dr. Mozaffar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alexion Pharmaceuticals. Dr. Mozaffar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Argenx. Dr. Mozaffar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Mozaffar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amicus. Dr. Mozaffar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Modis Therapeutics. Dr. Mozaffar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB/ Ra Pharmaceuticals. Dr. Mozaffar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Maze Therapeutics. Dr. Mozaffar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Spark Therapeutics. Dr. Mozaffar has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. Dr. Mozaffar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for National Institutes of Health. Dr. Mozaffar has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Argenx. Dr. Mozaffar has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for Neuromuscular Disease Foundation. The institution of Dr. Mozaffar has received research support from NIH. The institution of Dr. Mozaffar has received research support from Muscular Dystrophy Association. The institution of Dr. Mozaffar has received research support from Sanofi-Genzyme. The institution of Dr. Mozaffar has received research support from Argenx. The institution of Dr. Mozaffar has received research support from Amicus Therapeutics. The institution of Dr. Mozaffar has received research support from Spark Therapeutics. The institution of Dr. Mozaffar has received research support from Audentes Therapeutics. The institution of Dr. Mozaffar has received research support from Cartesian. Dr. Mozaffar has received personal compensation in the range of $500-$4,999 for serving as a Study Section Member with NIH.
Ersin Tan, MD Dr. Tan has nothing to disclose.
Katherine Fu, MD Dr. Fu has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Academy of Neurology: Neurology Journal .
Carole Drexel Carole Drexel has nothing to disclose.
Robin Warner, DO Dr. Warner has nothing to disclose.
Meltem Inci II, MD Dr. Inci has nothing to disclose.
Jamie Wong, PhD Dr. Wong has nothing to disclose.
Isela S. Hernandez Miss Hernandez has nothing to disclose.
Sarah Heintzman, NP Ms. Heintzman has nothing to disclose.
Anita Seto Anita Seto has received personal compensation for serving as an employee of Expansion Therapeutics. Anita Seto has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for miRagen Therapeutics. Anita Seto has received stock or an ownership interest from Expansion Therapeutics.
Pravesh Saini, MD Dr. Saini has nothing to disclose.
Ahmad Armouti, MD Dr. Armouti has nothing to disclose.
Cagri Mesut Temucin Cagri Mesut Temucin has nothing to disclose.
Kimberly R. McDonald, MD Dr. McDonald has nothing to disclose.
Jason C. Strawbridge Mr. Strawbridge has nothing to disclose.
Jeffrey Mullen, MD Dr. Mullen has nothing to disclose.
Prashant Natteru, MBBS Dr. Natteru has nothing to disclose.
Ezequiel A. Piccione, MD, FAAN Dr. Piccione has nothing to disclose.
Sumit Verma, MD Dr. Verma has nothing to disclose.
Ahmed A. Bayoumi Mr. Bayoumi has nothing to disclose.
Alexandra Montalvo Acevedo, MD Dr. Montalvo Acevedo has nothing to disclose.
Kelly Rich, MS, CGC Ms. Rich has nothing to disclose.
Nicolas Dupre, MD, FAAN Dr. Dupre has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Akcea Therapeutics Canada. The institution of Dr. Dupre has received research support from ARSACS Foundation. The institution of Dr. Dupre has received research support from CHUdeQuebec Foundation.
Namita Goyal, MD, FAAN Dr. Goyal has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Goyal has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genzyme. Dr. Goyal has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Goyal has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB . Dr. Goyal has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Astrazenica. Dr. Goyal has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kezar. Dr. Goyal has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Annexon. Dr. Goyal has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abcuro. Dr. Goyal has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Fulcrum. Dr. Goyal has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for CSL Behring. Dr. Goyal has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Argenx. The institution of Dr. Goyal has received research support from Brainstorm Cell Therapeutics. The institution of Dr. Goyal has received research support from Cytokinetics. The institution of Dr. Goyal has received research support from Fulcrum. The institution of Dr. Goyal has received research support from Kezar. The institution of Dr. Goyal has received research support from Alexion. The institution of Dr. Goyal has received research support from Annexon. The institution of Dr. Goyal has received research support from Annelixis. The institution of Dr. Goyal has received research support from Healey Platform. The institution of Dr. Goyal has received research support from Medicinova. The institution of Dr. Goyal has received research support from Amylyx. The institution of Dr. Goyal has received research support from MT Pharma. The institution of Dr. Goyal has received research support from Transposon. Dr. Goyal has received publishing royalties from a publication relating to health care.
Neil Manering, MD Dr. Manering has nothing to disclose.
Jose Maria Cabrera Maqueda Mr. Cabrera Maqueda has nothing to disclose.
Baha Abu-Esheh, MD, FAAN Dr. Abu-Esheh has received personal compensation for serving as an employee of BAHA Abu-eager, MD PC. Dr. Abu-Esheh has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Allergan. Dr. Abu-Esheh has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Amgen. Dr. Abu-Esheh has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Lilly.
Michael C. Hunter, MD Dr. Hunter has nothing to disclose.
Claire Ruane Ms. Ruane has nothing to disclose.
Joy Chan, MD Dr. Chan has nothing to disclose.
Ichizo Nishino, MD, PhD, FAAN The institution of Dr. Nishino has received research support from AMED.
Danielle Bazer, DO Dr. Bazer has nothing to disclose.
Teerin Liewluck, MD, FAAN Dr. Liewluck has nothing to disclose.
Sun Qiu, MD Dr. Qiu has nothing to disclose.
Kristin Johnson, DO Dr. Johnson has nothing to disclose.
Roberta Frigerio, MD Dr. Frigerio has nothing to disclose.
Jonathan Morena, DO The institution of Dr. Morena has received research support from Grifols.
Francesc R. Graus, MD Dr. Graus has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MedLink. Dr. Graus has received intellectual property interests from a discovery or technology relating to health care.
Nicholas S. Streicher, MD Dr. Streicher has nothing to disclose.
Abdullah Ishaque Abdullah Ishaque has nothing to disclose.
Mamatha Pasnoor, MD, FAAN Dr. Pasnoor has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Argenx BVBA. Dr. Pasnoor has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Takeda Pharmaceuticals. Dr. Pasnoor has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen Pharmaceutical. Dr. Pasnoor has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunovant. Dr. Pasnoor has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Pasnoor has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for catalyst pharmaceuticals. Dr. Pasnoor has received research support from NIH.
Francesca Palumbo No disclosure on file
Fiona M. Molloy, MD Dr. Molloy has nothing to disclose.
Tanya Panwala, MD Miss Panwala has nothing to disclose.
Matthias Weigel, PhD The institution of Matthias Weigel, PhD has received research support from Biogen. Matthias Weigel, PhD has received intellectual property interests from a discovery or technology relating to health care.
Ammar Al-Chalabi, PhD, FRCP DipStat The institution of Dr. Al-Chalabi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for OrionPharma. The institution of Dr. Al-Chalabi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cytokinetics Inc. The institution of Dr. Al-Chalabi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi Tanabe Pharma. The institution of Dr. Al-Chalabi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amylyx. The institution of Dr. Al-Chalabi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Quralis. Dr. Al-Chalabi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for My Name'5 Doddie Foundation. The institution of Dr. Al-Chalabi has received research support from Medical Research Council. The institution of Dr. Al-Chalabi has received research support from NIHR. The institution of Dr. Al-Chalabi has received research support from European Commission. The institution of Dr. Al-Chalabi has received research support from MND Association. The institution of Dr. Al-Chalabi has received research support from My Name'5 Doddie Foundation. Dr. Al-Chalabi has received publishing royalties from a publication relating to health care. Dr. Al-Chalabi has received publishing royalties from a publication relating to health care. Dr. Al-Chalabi has a non-compensated relationship as a SAB Member and Executive Member with TRICALS that is relevant to AAN interests or activities.
Gregory S. Day, MD, MSc, FAAN Dr. Day has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Parabon Nanolabs. The institution of Dr. Day has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eli Lilly. Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arialys Therapeutics. Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ionis. Dr. Day has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for DynaMed (EBSCO Health). Dr. Day has stock in ANI Pharmaceuticals. The institution of Dr. Day has received research support from National Institutes of Health / NIA. The institution of Dr. Day has received research support from Chan Zuckerberg Initiative. The institution of Dr. Day has received research support from Alzheimer's Association. The institution of Dr. Day has received research support from National Institutes of Health / NINDS. The institution of Dr. Day has received research support from Horizon Therapeutics. The institution of Dr. Day has received research support from AVID Radiopharmaceuticals. Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a Presenter at Annual Meeting (CME) with American Academy of Neurology. Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a Content Development (CME) with PeerView, Inc. Dr. Day has received personal compensation in the range of $5,000-$9,999 for serving as a Content Development (CME) with Continuing Education, Inc. Dr. Day has a non-compensated relationship as a Clinical Director with AntiNMDA Receptor Encephalitis Foundation that is relevant to AAN interests or activities.
Duaa Jabari, MD Dr. Jabari has nothing to disclose.
Arman Cakar Arman Cakar has nothing to disclose.
Lisa Hobson-Webb, MD, FAAN An immediate family member of Dr. Hobson-Webb has received personal compensation for serving as an employee of G1 Therapeutics. Dr. Hobson-Webb has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wiley Publishing. The institution of Dr. Hobson-Webb has received research support from Sanofi Genzyme.
Adeel Zubair, MD Dr. Zubair has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for The MedNet.
Stefan Nicolau, MD The institution of Dr. Nicolau has received research support from Muscular Dystrophy association. The institution of Dr. Nicolau has received research support from American Brain Foundation. The institution of Dr. Nicolau has received research support from American Neuromuscular Foundation.
Toshiyuki Yamamoto Dr. Yamamoto has nothing to disclose.
Risako Shirane, MD, MSc Dr. Shirane has nothing to disclose.
Bakri Elsheikh, MD, FAAN Dr. Elsheikh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen . Dr. Elsheikh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argnex . The institution of Dr. Elsheikh has received research support from Biogen. The institution of Dr. Elsheikh has received research support from Cure SMA.
Natalie Katz, MD, PhD Dr. Katz has nothing to disclose.
Stanley J. Iyadurai, MD, PhD, FAAN Dr. Iyadurai has received personal compensation for serving as an employee of Catalyst Pharmaceuticals. Dr. Iyadurai has received stock or an ownership interest from Catalyst Pharmaceuticals.
Tarrant McPherson Tarrant McPherson has received research support from Myasthenia Gravis Foundation of America.
Hannah R. Briemberg, MD, FRCPC Dr. Briemberg has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. The institution of an immediate family member of Dr. Briemberg has received research support from CIHR. Dr. Briemberg has received publishing royalties from a publication relating to health care. An immediate family member of Dr. Briemberg has received publishing royalties from a publication relating to health care.
Brian J. Villafuerte Trisolini, MD Dr. Villafuerte Trisolini has nothing to disclose.
Haroon Majoka, MD Dr. Majoka has nothing to disclose.
Lawrence A. Zeidman, MD, FAAN Dr. Zeidman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer. Dr. Zeidman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dr. Zeidman has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Grifols. The institution of Dr. Zeidman has received research support from Octapharma. Dr. Zeidman has received publishing royalties from a publication relating to health care.
James D. Triplett, MBBS Dr. Triplett has nothing to disclose.
Swathy Chandrashekhar, MD Dr. Chandrashekhar has received publishing royalties from a publication relating to health care.
John L. Berk John L. Berk has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alnylam Pharmaceuticals. John L. Berk has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ionis Pharmaceuticals. John L. Berk has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astra Zeneca/IONIS. John L. Berk has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eidos/BridgBio. John L. Berk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Intellia Therapeutics. John L. Berk has received research support from Alnylam . John L. Berk has received research support from Ionis. John L. Berk has received research support from Eidos/Bridgbio.
Nour Jedidi Nour Jedidi has nothing to disclose.
Deborah Setter, MD, PhD Dr. Setter has nothing to disclose.
Michael Sinnreich, MD, PhD Prof. Sinnreich has nothing to disclose.
Yongsheng Chen, PhD Dr. Chen has nothing to disclose.
Nicholas J. Silvestri, MD, FAAN Dr. Silvestri has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for argenx. Dr. Silvestri has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. Dr. Silvestri has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Regeneron. Dr. Silvestri has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Strongbridge. Dr. Silvestri has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Silvestri has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Silvestri has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunovant. Dr. Silvestri has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for argenx. Dr. Silvestri has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Silvestri has received publishing royalties from a publication relating to health care.
Andres De Leon Benedetti, MD Dr. De Leon Benedetti has nothing to disclose.
Jorge E. Patino Murillas, MD Dr. Patino Murillas has nothing to disclose.
Teresa Coelho, MD Dr. Coelho has nothing to disclose.
Peter Q. Mai, MD Dr. Mai has nothing to disclose.
Micaela Kennedy, MSc Miss Kennedy has nothing to disclose.
Sanjay Kalra, MD The institution of Dr. Kalra has received research support from Brain Canada Foundation. The institution of Dr. Kalra has received research support from Biogen.
Anuj Dhir, MD Dr. Dhir has nothing to disclose.
Melissa J. Rethana, MD Dr. Rethana has nothing to disclose.
Maria Sepúlveda No disclosure on file
Jun Li, MD, PhD, FAAN The institution of Dr. Li has received personal compensation in the range of $500-$4,999 for serving as a Consultant for FDA. The institution of Dr. Li has received research support from NIH. Dr. Li has a non-compensated relationship as a Associate Editor of ACTN journal with ANA that is relevant to AAN interests or activities.
Aysegul Akkan Suzan Aysegul Akkan Suzan has nothing to disclose.
Aziz I. Shaibani, MD, FAAN Dr. Shaibani has nothing to disclose.
Erin K. O'Ferrall, MD The institution of Dr. O'Ferrall has received research support from Sanofi Genzyme. The institution of Dr. O'Ferrall has received research support from Harmony Biosciences. The institution of Dr. O'Ferrall has received research support from Fulcrum Therapeutics. The institution of Dr. O'Ferrall has received research support from Roche Pharmaceuticals. Dr. O'Ferrall has received publishing royalties from a publication relating to health care.
Alan Evans, PhD Dr. Evans has received personal compensation for serving as an employee of biospective. Dr. Evans has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for biospective.
John Brandsema, MD Dr. Brandsema has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Brandsema has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Brandsema has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for PTC Therapeutics. Dr. Brandsema has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sarepta. Dr. Brandsema has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Brandsema has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Argenx. Dr. Brandsema has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Janssen. Dr. Brandsema has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dyne. Dr. Brandsema has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Fibrogen. Dr. Brandsema has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Dr. Brandsema has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Edgewise. The institution of Dr. Brandsema has received research support from Novartis. The institution of Dr. Brandsema has received research support from Biogen. The institution of Dr. Brandsema has received research support from Alexion. The institution of Dr. Brandsema has received research support from CSL Behring. The institution of Dr. Brandsema has received research support from Pfizer. The institution of Dr. Brandsema has received research support from PTC Therapeutics. The institution of Dr. Brandsema has received research support from Sarepta. The institution of an immediate family member of Dr. Brandsema has received research support from Argenx. The institution of Dr. Brandsema has received research support from Astellas. The institution of Dr. Brandsema has received research support from Fibrogen. The institution of Dr. Brandsema has received research support from Genentech. The institution of Dr. Brandsema has received research support from Janssen. The institution of Dr. Brandsema has received research support from Scholar Rock.
Chad Hoyle, MD Dr. Hoyle has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for National Football League. Dr. Hoyle has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avexis. Dr. Hoyle has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Reata. The institution of Dr. Hoyle has received research support from REATA. The institution of Dr. Hoyle has received research support from TAKEDA.
Tara C. Lincoln, MS No disclosure on file
Bhavesh Trikamji, MD Dr. Trikamji has nothing to disclose.
Husam Al Sultani No disclosure on file
Gary R. Cutter, PhD Dr. Cutter has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biodelivery Sciences International, Biogen, Click Therapeutics, Genzyme, Genentech, GW Pharmaceuticals, Immunic, Klein-Buendel Incorporated, Medimmune/Viela Bio, Medday, Merck/Serono, Neurogenesis LTD, Novartis, Osmotica Pharmaceuticals, Perception Neurosciences, Recursion/Cerexis Pharmaceuticals, Regeneron, Reckover Pharmaceuticals, Roche, TG Therapeutics.. Dr. Cutter has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Applied Therapeutics, AI therapeutics, AMO Pharma, Astra-Zeneca, Avexis Pharmaceuticals, Biolinerx, Brainstorm Cell Therapeutics, Bristol Meyers Squibb/Celgene, CSL Behring, Galmed Pharmaceuticals, Green Valley Pharma, Horizon Pharmaceuticals, Immunic, Karuna Therapeutics, Mapi Pharmaceuticals LTD, Merck, Mitsubishi Tanabe Pharma Holdings, Opko Biologics,Prothena Biosciences, Novartis, Regeneron, Sanofi-Aventis, Reata Pharmaceuticals, NHLBI (Protocol Review Committee), University of Texas Southwestern, University of Pennsylvania, Visioneering Technologies, Inc.. Dr. Cutter has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JASN.
Andrea Calvo, MD, PhD, FAAN Dr. Calvo has nothing to disclose.
Nivedita Jerath, MD Dr. Jerath has nothing to disclose.
Takayoshi Shimohata, MD, FAAN Dr. Shimohata has nothing to disclose.
Yuwei Da, MD Dr. Da has nothing to disclose.
Ojas Srivastava Mr. Srivastava has nothing to disclose.
Eugenia Martinez-Hernandez, MD The institution of Dr. Martinez-Hernandez has received research support from Instituto de Salud Carlos III. Dr. Martinez-Hernandez has received personal compensation in the range of $0-$499 for serving as a travel and speaking honoraria with Biogen. Dr. Martinez-Hernandez has received personal compensation in the range of $0-$499 for serving as a travel honoraria with UCB.
John R. Mills, MD, PhD The institution of Dr. Mills has received research support from Werfen Diagnostics. Dr. Mills has received intellectual property interests from a discovery or technology relating to health care.
Jonathan Cauchi, MD Dr. Cauchi has nothing to disclose.
Joerg B. Schulz, MD Dr. Schulz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Schulz has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Society for Neurochemistry.
Julaine M. Florence Ms. Florence has nothing to disclose.
Cristina Granziera, MD, PhD Dr. Granziera has nothing to disclose.
Megan M. Shanks, MD Dr. Shanks has nothing to disclose.
Mary K. Schroth, MD Dr. Schroth has received personal compensation for serving as an employee of Cure SMA. The institution of Dr. Schroth has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. The institution of Dr. Schroth has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. The institution of Dr. Schroth has received research support from Biogen.
John Herbst, DO Dr. Herbst has nothing to disclose.
Varun Sreenivasan, MD Dr. Sreenivasan has nothing to disclose.
Leah D. Brancheck, MD Dr. Brancheck has nothing to disclose.
Shannon M. LaBoy, MD Dr. LaBoy has nothing to disclose.
Karina L. Pires, MD Dr. Pires has nothing to disclose.
Carl F. Ansevin, MD, FAAN Dr. Ansevin has nothing to disclose.
Madoka Mori-Yoshimura, MD, PhD Dr. Mori-Yoshimura has nothing to disclose.
Saurabh G. Shukla, MD Dr. Shukla has nothing to disclose.
Nadia M. Celestin, BS Miss Celestin has nothing to disclose.
Mailin Oliva, MD Dr. Oliva has nothing to disclose.
Ikjae Lee, MD Dr. Lee has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Lee has received personal compensation in the range of $0-$499 for serving as a Consultant for Amylyx. Dr. Lee has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Regeneron. The institution of Dr. Lee has received research support from Myasthenia Gravis Foundation of America. The institution of Dr. Lee has received research support from CReATe consortium/American Brain Foundation. The institution of Dr. Lee has received research support from NIH.
Erik P. Pioro, MD, DPhil, FAAN Dr. Pioro has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avanir Pharmaceutical, Inc.. Dr. Pioro has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amylyx Pharmaceuticals. Dr. Pioro has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. Dr. Pioro has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MT Pharma America, Inc.. Dr. Pioro has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NeuroTherapia, Inc.. Dr. Pioro has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MT Pharma America, Inc..
Michael T. Pulley, MD, PhD Dr. Pulley has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion`. Dr. Pulley has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MT Pharma. Dr. Pulley has received personal compensation in the range of $500-$4,999 for serving as a Consultant for amylyx. Dr. Pulley has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Pulley has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Argenx. Dr. Pulley has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Pulley has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for Multiple law firms.
Janice M. Massey, MD, FAAN Dr. Massey has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenix. Dr. Massey has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Revance Therapeutics. Dr. Massey has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Momenta. The institution of Dr. Massey has received research support from Revance .
Sara Hooshmand, MD Dr. Hooshmand has nothing to disclose.
Seung Ah Kang Seung Ah Kang has nothing to disclose.
Grant Turek, MD Dr. Turek has nothing to disclose.
Seth Arum Seth Arum has received personal compensation for serving as an employee of Alnylam Pharmaceuticals. Seth Arum has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wolters Kluwer.
Collin C. Luk, MD Dr. Luk has nothing to disclose.
Elizabeth Leon Elizabeth Leon has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for BIOGEN AND SANOFI.
Aaron Zelikovich, MD Dr. Zelikovich has nothing to disclose.
Maria M. Khan, MD No disclosure on file
Marie Wencel, CCRP Ms. Wencel has nothing to disclose.
David C. Taylor, MD No disclosure on file
Swathi Beladakere Ramaswamy, MD Dr. Beladakere Ramaswamy has nothing to disclose.
Anna Mazzeo, MD Dr. Mazzeo has nothing to disclose.
Kenichiro Taira, MD, PhD Dr. Taira has nothing to disclose.
Steven Shook, MD Dr. Shook has nothing to disclose.
Elina Zakin, MD The institution of Dr. Zakin has received research support from American Board of Psychiatry and Neurology.
Mohammed W. Rahman, DO Dr. Rahman has nothing to disclose.
Leonard H. Van den Berg, MD The institution of Dr. Van den Berg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amylyx. The institution of Dr. Van den Berg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ferrrer. The institution of Dr. Van den Berg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. The institution of Dr. Van den Berg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. The institution of Dr. Van den Berg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda. The institution of Dr. Van den Berg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Van den Berg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS. The institution of Dr. Van den Berg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ArgenX. The institution of Dr. Van den Berg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Projenx. The institution of Dr. Van den Berg has received research support from Netherlands ALS Foundation.
Eric L. Marin, MD Dr. Marin has nothing to disclose.
Amro Stino, MD Dr. Stino has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ClearView Healthcare Partners. Dr. Stino has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MedVal Scientific Information Services. The institution of Dr. Stino has received research support from GBS-CIDP Foundation. Dr. Stino has received personal compensation in the range of $500-$4,999 for serving as a Consultant with PCORI.
Jing Marantz No disclosure on file
Adrian Marchidann, MD Dr. Marchidann has stock in Eli Lilly. Dr. Marchidann has stock in Pfizer. Dr. Marchidann has stock in Merck. Dr. Marchidann has stock in Illumina. Dr. Marchidann has stock in Aeterna Zentaris. Dr. Marchidann has stock in Abbot. Dr. Marchidann has received publishing royalties from a publication relating to health care. Dr. Marchidann has received publishing royalties from a publication relating to health care.
Lucas Alessandro, Sr., MD Dr. Alessandro has nothing to disclose.
Volkan Granit, MD Dr. Granit has received personal compensation for serving as an employee of Biohaven Pharmaceuticals. Dr. Granit has stock in Biohaven. Dr. Granit has received personal compensation in the range of $10,000-$49,999 for serving as a Faculty Member with University of Miami. Dr. Granit has a non-compensated relationship as a collaborator in clinical trial design with Cartesian Therapeutics that is relevant to AAN interests or activities.
Nizar Souayah, MD, FAAN Dr. Souayah has received publishing royalties from a publication relating to health care.
Brian Crum, MD Dr. Crum has nothing to disclose.
Kristina M. Kelly, PT Dr. Kelly has nothing to disclose.
Constantine Farmakidis, MD, FAAN Dr. Farmakidis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Momenta. Dr. Farmakidis has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx.
Kira M. Holmström, PhD Kira Holmström has received personal compensation for serving as an employee of Orion Pharma, Orion Corporation.
Javier A. Galnares-Olalde, Jr., MD Dr. Galnares-Olalde has nothing to disclose.
Raquel Norel Raquel Norel has received personal compensation for serving as an employee of IBM. Raquel Norel has received intellectual property interests from a discovery or technology relating to health care.
Octavia B. Kincaid, MD Dr. Kincaid has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GLG Group.
Gerard M. Mullins, MD Dr. Mullins has nothing to disclose.
Maria Janina Wendebourg, MD Dr. Wendebourg has nothing to disclose.
Umberto Manera, MD Dr. Manera has nothing to disclose.
Eoin P. Flanagan, MBBCh, FAAN The institution of Dr. Flanagan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Flanagan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Flanagan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon Therapeutics. The institution of Dr. Flanagan has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Flanagan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Pharmacy times. The institution of Dr. Flanagan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for UCB. The institution of Dr. Flanagan has received research support from Viela Bio. The institution of Dr. Flanagan has received research support from UCB. The institution of Dr. Flanagan has received research support from Roche. Dr. Flanagan has received publishing royalties from a publication relating to health care. Dr. Flanagan has a non-compensated relationship as a Member of medical Advisory Board with The MOG Project that is relevant to AAN interests or activities. Dr. Flanagan has a non-compensated relationship as a Editorial board member with Journal of The Neurologic Sciences that is relevant to AAN interests or activities. Dr. Flanagan has a non-compensated relationship as a Editorial board member with Neuroimmunology Reports that is relevant to AAN interests or activities. Dr. Flanagan has a non-compensated relationship as a Editorial Board Member with Neurology, Neuroimmunology Neuroinflammation (N2) Journal that is relevant to AAN interests or activities.
Rosario Vasta, MD Dr. Vasta has nothing to disclose.
Manisha Kak Korb, MD Dr. Kak Korb has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Kak Korb has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CSL Behring. Dr. Kak Korb has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Kak Korb has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen.
Han Phan, MD Dr. Phan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Wave Biosciences. Dr. Phan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Stealth.
Hacer Durmus, MD Dr. Durmus has nothing to disclose.
Donald B. Sanders, MD, FAAN Dr. Sanders has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Accordant Health Services. Dr. Sanders has received personal compensation in the range of $0-$499 for serving as a Consultant for Cabaletta BIO. Dr. Sanders has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kashiv Biosciences. Dr. Sanders has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Momenta Pharmaceuticals. Dr. Sanders has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen RnD. Dr. Sanders has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi-aventis. Dr. Sanders has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for VielaBio. Dr. Sanders has received publishing royalties from a publication relating to health care.
Anthony J. Windebank, MD, FAAN Dr. Windebank has nothing to disclose.
Vern C. Juel, MD, FAAN Dr. Juel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunovant. Dr. Juel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Juel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Accordant Health Services. Dr. Juel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. The institution of Dr. Juel has received research support from argenx. The institution of Dr. Juel has received research support from Alexion. The institution of Dr. Juel has received research support from Janssen. The institution of Dr. Juel has received research support from NIH Rare Diseases Network.
John W. Day, MD, PhD Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Affinia Therapeutics. Dr. Day has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis Gene Therapy. Dr. Day has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Day has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/Genentech. Dr. Day has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. Dr. Day has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Scholar Rock. Dr. Day has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avidity. Dr. Day has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Muscular Dystrophy Association. The institution of Dr. Day has received research support from Audentes. The institution of Dr. Day has received research support from Novartis Gene Therapy. The institution of Dr. Day has received research support from Biogen. The institution of Dr. Day has received research support from Cytokinetics. The institution of Dr. Day has received research support from Roche/Genentech. The institution of Dr. Day has received research support from Sanofi/Genzyme. The institution of Dr. Day has received research support from Sarepta. The institution of Dr. Day has received research support from Scholar Rock. Dr. Day has received intellectual property interests from a discovery or technology relating to health care.
Marianne De Visser, MD, PhD Dr. De Visser has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avexis. Dr. De Visser has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS. Dr. De Visser has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Dynacure.
Yessar M. Hussain, MD The institution of Dr. Hussain has received research support from Alnylam Pharma.
Elisa G. Gouvea Elisa Gouvea has nothing to disclose.
DeWitt D. Pyburn, MD Dr. Pyburn has nothing to disclose.
Maike Dohrn, MD Dr. Dohrn has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Akcea, Alnylam, Pfizer, Amicus. Dr. Dohrn has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amicus, Akcea. Dr. Dohrn has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Akcea, Alnylam, Pfizer. The institution of Dr. Dohrn has received research support from Pfizer. Dr. Dohrn has received research support from German Research Foundation.
Jennifer D. Hauteclocque Miss Hauteclocque has nothing to disclose.
Ludwig Kappos, MD, FAAN The institution of Dr. Kappos has received research support from Bayer. The institution of Dr. Kappos has received research support from Biogen. The institution of Dr. Kappos has received research support from Genentech. The institution of Dr. Kappos has received research support from Genzyme. The institution of Dr. Kappos has received research support from Janssen. The institution of Dr. Kappos has received research support from Merck Serono. The institution of Dr. Kappos has received research support from Minoryx. The institution of Dr. Kappos has received research support from Novartis. The institution of Dr. Kappos has received research support from Roche. The institution of Dr. Kappos has received research support from Sanofi. The institution of Dr. Kappos has received research support from Santhera. The institution of Dr. Kappos has received research support from Swiss MS Society, Swiss National Research Foundation, European Union, Roche Research Foundation, Innosuisse. The institution of Dr. Kappos has received research support from Shionogi. The institution of Dr. Kappos has received research support from Japan Tobacco. The institution of Dr. Kappos has received research support from Auriga Vision AG. The institution of Dr. Kappos has received research support from EMD Serono. The institution of Dr. Kappos has received research support from Glaxo Smith Kline. The institution of Dr. Kappos has received research support from Wellmera AG. The institution of Dr. Kappos has received research support from Eli Lilly (Suisse) SA. The institution of Dr. Kappos has received research support from Bristol Myers Squibb. The institution of Dr. Kappos has received research support from Celltrion Inc. Dr. Kappos has received intellectual property interests from a discovery or technology relating to health care.
Adib Jorge De Sarachaga, MD Dr. Jorge De Sarachaga has nothing to disclose.
Mar Guasp, MD Dr. Guasp has nothing to disclose.
Jeffrey Statland, MD Dr. Statland has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arrowhead. Dr. Statland has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ML Bio. Dr. Statland has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MT Pharma. Dr. Statland has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Epic Bio. Dr. Statland has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Armatus . Dr. Statland has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Dyne Therapeutics. Dr. Statland has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avidity . Dr. Statland has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Fulcrum Therapeutics. Dr. Statland has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. The institution of Dr. Statland has received research support from NIH. The institution of Dr. Statland has received research support from FSHD Society. The institution of Dr. Statland has received research support from Friends of FSH Research. The institution of Dr. Statland has received research support from FSHD Canada. The institution of Dr. Statland has received research support from MDA.
Joseph M. Beaty Mr. Beaty has nothing to disclose.